Exclusive Breastfeeding from Birth to 6 Months for Reducing Community Acquired Pneumonia in Children Up to 5 Years of Age: A Systematic Review and Meta-Analysis

Vanessa Amor Dizon- Ditangco, Rebecca Abiog-Castro
{"title":"Exclusive Breastfeeding from Birth to 6 Months for Reducing Community Acquired Pneumonia in Children Up to 5 Years of Age: A Systematic Review and Meta-Analysis","authors":"Vanessa Amor Dizon- Ditangco, Rebecca Abiog-Castro","doi":"10.56964/pidspj20202102003","DOIUrl":null,"url":null,"abstract":"Background: Exclusive breastfeeding up to 6 months of age is the global recommendation of the World Health Organization because of its established benefits. Previous studies show that exclusive breastfeeding can protect infants during infancy but effects of breastfeeding beyond infancy are inconclusive. This study aims to identify if exclusive breastfeeding up to 6 months of age is protective for pneumonia up to 5 years of age. Methods: Systematic literature search was conducted on the following electronic databases: Pubmed, MEDLINE, EMBASE, CINAHL, SciHub, Herdin, Google Scholar, the Cochrane Central Register of Controlled Trials and the Cochrane Database of Systematic Reviews to identify all relevant studies assessing the effect of exclusive breastfeeding on development of pneumonia in children from birth to 5 years of age. Fixed effects meta-analysis was performed to generate pooled effect estimates (odds ratio) on the probability of developing pneumonia up to 5 years of age in exclusively breastfed compared to non-exclusively breastfed infants. Results: Five studies were included in the analysis. Exclusive breastfeeding from birth to 6 months has a protective effect against pneumonia in children up to 5 years of age. The probability of developing pneumonia in children until 5 years of age was significantly lower in those who were exclusively breastfed compared to those who were not exclusively breastfed (OR=0.86; 95%CI=0.77-0.95, pvalue=0.003) by 23%. Systematic review showed benefit of exclusive breastfeeding and continued breastfeeding for longer protection against developing pneumonia. Conclusion: Exclusive breastfeeding from birth to 6 months is associated with statistically significant reduction in the incidence of pneumonia up to 5 years of age. Results highlighted the importance of exclusive breastfeeding up to 6 months of age as an intervention in reducing pneumonia morbidity up to 5 years of age, thereby supporting the global recommendation of breastfeeding.","PeriodicalId":117545,"journal":{"name":"Pediatric Infectious Disease Society of the Philippines Journal","volume":"31 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Infectious Disease Society of the Philippines Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.56964/pidspj20202102003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Exclusive breastfeeding up to 6 months of age is the global recommendation of the World Health Organization because of its established benefits. Previous studies show that exclusive breastfeeding can protect infants during infancy but effects of breastfeeding beyond infancy are inconclusive. This study aims to identify if exclusive breastfeeding up to 6 months of age is protective for pneumonia up to 5 years of age. Methods: Systematic literature search was conducted on the following electronic databases: Pubmed, MEDLINE, EMBASE, CINAHL, SciHub, Herdin, Google Scholar, the Cochrane Central Register of Controlled Trials and the Cochrane Database of Systematic Reviews to identify all relevant studies assessing the effect of exclusive breastfeeding on development of pneumonia in children from birth to 5 years of age. Fixed effects meta-analysis was performed to generate pooled effect estimates (odds ratio) on the probability of developing pneumonia up to 5 years of age in exclusively breastfed compared to non-exclusively breastfed infants. Results: Five studies were included in the analysis. Exclusive breastfeeding from birth to 6 months has a protective effect against pneumonia in children up to 5 years of age. The probability of developing pneumonia in children until 5 years of age was significantly lower in those who were exclusively breastfed compared to those who were not exclusively breastfed (OR=0.86; 95%CI=0.77-0.95, pvalue=0.003) by 23%. Systematic review showed benefit of exclusive breastfeeding and continued breastfeeding for longer protection against developing pneumonia. Conclusion: Exclusive breastfeeding from birth to 6 months is associated with statistically significant reduction in the incidence of pneumonia up to 5 years of age. Results highlighted the importance of exclusive breastfeeding up to 6 months of age as an intervention in reducing pneumonia morbidity up to 5 years of age, thereby supporting the global recommendation of breastfeeding.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
从出生到6个月的纯母乳喂养可减少5岁以下儿童的社区获得性肺炎:一项系统综述和荟萃分析
背景:6个月以内的纯母乳喂养是世界卫生组织的全球建议,因为它具有公认的益处。以前的研究表明,纯母乳喂养可以在婴儿期保护婴儿,但婴儿期以后母乳喂养的影响尚无定论。本研究旨在确定6个月以下的纯母乳喂养是否对5岁以下的肺炎有保护作用。方法:系统检索Pubmed、MEDLINE、EMBASE、CINAHL、SciHub、Herdin、Google Scholar、Cochrane中央对照试验注册库和Cochrane系统评价数据库等电子数据库的文献,以确定所有评估纯母乳喂养对出生至5岁儿童肺炎发展影响的相关研究。进行固定效应荟萃分析,对纯母乳喂养与非纯母乳喂养的婴儿在5岁前发生肺炎的概率进行综合效应估计(优势比)。结果:5项研究被纳入分析。从出生到6个月的纯母乳喂养对5岁以下儿童的肺炎具有保护作用。纯母乳喂养的5岁以下儿童患肺炎的概率显著低于非纯母乳喂养的儿童(OR=0.86;95%CI=0.77-0.95, pvalue=0.003)差23%。系统评价显示,纯母乳喂养和持续母乳喂养对预防肺炎有更长的保护作用。结论:从出生到6个月的纯母乳喂养与5岁以下肺炎发病率的统计学显著降低相关。研究结果强调了6个月前纯母乳喂养作为降低5岁前肺炎发病率的干预措施的重要性,从而支持了母乳喂养的全球建议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Clinical Profile and Treatment Outcomes Of Acute Cholangitis in Children in a Tertiary Government Hospital in the Philippines: A Five-Year Retrospective Study. SARS-CoV-2 RT-PCR cycle threshold value and its association with disease severity and mortality among hospitalized pediatric covid-19 patients. Clinical and Microbiological Profile and Factors Affecting Outcome among Pediatric Febrile Neutropenic Patients with Hematologic Malignancies. Aye, AI Captain! The Coronavirus Disease 2019 (COVID-19) Immunoglobulin (IgG) Levels Using Chemiluminescence Immunoassay (CLIA) Anti-S-RBD Test in Term Neonates Born to COVID-19 Fully Vaccinated Mothers
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1